Stanley C Erck Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Stanley C Erck.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Stanley C Erck. Stanley C Erck is a Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and a CEO and President in NOVAVAX INC ($NVAX) and a President and CEO in NOVAVAX INC ($NVAX) and a President & CEO in INTERCELL USA, INC. ($IOMI) and a President and CEO in INTERCELL USA, INC. ($IOMI).
Address: 20 FIRSTFIELD ROAD SUITE 250 GAITHERSBURG 20878 MD
Companies in which Stanley C Erck is an Insider
BIOCRYST PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Stanley C Erck: Director
Holdings: 48,333 shares
Current Value: $274,048
Latest Transaction: Nov 30 2018
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INTERCELL USA, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Stanley C Erck: President & CEO, President and CEO
Holdings: 25,000 shares
Latest Transaction: Jan 04 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NOVAVAX INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Stanley C Erck: President and CEO, CEO and President
Holdings: 49,606 shares
Current Value: $64,984
Latest Transaction: Dec 16 2020
$NVAX Market Capitalization: $355.26M
$NVAX Previous Close: $1.31
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Stanley C Erck
Sentiment: All, BCRX, IOMI, NVAX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | A | 0.00 | 20,900 | 0 | 20,900 | |
| Dec 16 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | A | 129.70 | 41,700 | 5,408,490 | 41,700 | |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | M | 5.95 | 25,000 | 148,750 | 75,000 | |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | M | 5.95 | 25,000 | 148,750 | 75,000 | |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Sell | S | 109.25 | 1,000 | 109,251 | 32,727 | 33.7 K to 32.7 K (-2.96 %) |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Sell | S | 108.40 | 1,112 | 120,544 | 33,727 | 34.8 K to 33.7 K (-3.19 %) |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Sell | S | 107.25 | 1,000 | 107,248 | 34,839 | 35.8 K to 34.8 K (-2.79 %) |